Does the amended ARTIVION (AORT) Form 4 involve any share sales by Marna Borgstrom?

The amended Form 4 shows only a restricted stock award acquisition and no share sales. It corrects administrative details of the prior grant report, including dates and share counts, and does not add or report any disposition or open-market sale transactions.

Artivion (AORT) director corrects details of restricted stock award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Borgstrom Marna P reported acquisition or exercise transactions in this Form 4 filing.

ARTIVION, INC. director Marna P. Borgstrom corrected a previously reported equity grant on an amended insider filing. The filing confirms a restricted stock award of 7,576 common shares granted on May 18, 2026, at no cost, which will vest on May 18, 2027, under the company’s Equity and Cash Incentive Plan.

After this correction, Borgstrom is shown as beneficially owning 56,664 common shares directly. The amendment states these changes fix administrative errors in the original Form 4 regarding the grant date, share amount, vesting date, and reported total holdings, with no other changes made.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Borgstrom Marna P

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,576	$0.00	--

Holdings After Transaction: Common Stock — 56,664 shares (Direct, null)

Footnotes (1)

This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Key Figures

Restricted stock award size: 7,576 shares Grant price per share: $0.0000 per share Holdings after transaction: 56,664 shares +3 more

6 metrics

Restricted stock award size 7,576 shares Common Stock granted on May 18, 2026

Grant price per share $0.0000 per share Restricted stock award to director

Holdings after transaction 56,664 shares Beneficially owned following award correction

Vesting date May 18, 2027 RSA vests under Equity and Cash Incentive Plan

Previously reported award size 7,850 shares Original, incorrect grant amount corrected by amendment

Previously reported holdings 56,938 shares Original, incorrect beneficial ownership now corrected

Key Terms

restricted stock award, beneficially owned, RSA Grant, Equity and Cash Incentive Plan, +1 more

5 terms

restricted stock award financial

"The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

beneficially owned financial

"the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

RSA Grant financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan"

Equity and Cash Incentive Plan financial

"pursuant to the terms of the Equity and Cash Incentive Plan"

administrative error financial

"correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/20/2026 - 09:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Borgstrom Marna P

(Last)

(First)

(Middle)

ARTIVION INC

1655 ROBERTS BLVD NW

(Street)

KENNESAW

GEORGIA

30144

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/19/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/18/2026⁽¹⁾		A		7,576⁽¹⁾⁽²⁾	A	$0	56,664⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment.

2. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Marna Borgstrom	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ARTIVION (AORT) director Marna Borgstrom report?

Director Marna P. Borgstrom reported a corrected grant of 7,576 shares of ARTIVION common stock. The shares are a restricted stock award granted at no cost and reflected as directly beneficially owned following the amendment to her original Form 4 filing.

Why did ARTIVION (AORT) file an amended Form 4 for Marna Borgstrom?

The amended Form 4 corrects administrative errors in the original report. It updates the grant date, number of restricted shares, vesting date, and the total number of securities beneficially owned, while confirming no other changes are being made to the previously reported information.

How many ARTIVION (AORT) shares were granted to Marna Borgstrom in this award?

The restricted stock award to Marna P. Borgstrom consists of 7,576 shares of ARTIVION common stock. The amendment clarifies this figure, replacing the previously reported 7,850 shares that were incorrectly stated in the original Form 4 filing for this grant.

When will Marna Borgstrom’s ARTIVION (AORT) restricted stock award vest?

The restricted stock award to Marna P. Borgstrom will vest on May 18, 2027. This vesting schedule is described as occurring pursuant to the terms of ARTIVION’s Equity and Cash Incentive Plan and replaces an earlier, incorrect vesting date previously reported.

What are Marna Borgstrom’s total ARTIVION (AORT) holdings after the corrected grant?

Following the corrected grant details, Borgstrom is reported as beneficially owning 56,664 ARTIVION common shares. This replaces a previously reported figure of 56,938 shares and reflects the updated, accurate share count from the amended Form 4 filing.